Catheter Precision, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
VTAK$0.15-0.7%Stored close · as of Oct 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets
(in thousands, except per share data)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $1,075 | $2,873 |
| Trading debt securities | 981 | — |
| Accounts receivable, net | 123 | 70 |
| Inventories | 34 | 33 |
| Prepaid expenses and other current assets | 254 | 316 |
| Total current assets | 2,467 | 3,292 |
| Property and equipment, net | 72 | 91 |
| Operating lease right-of-use assets, net | 184 | 105 |
| Intangible assets, net | 22,742 | 24,274 |
| Other non-current assets | 8 | 8 |
| TOTAL ASSETS | $25,473 | $27,770 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current Liabilities | ||
| Accounts payable | $1,079 | $230 |
| Accrued expenses | 1,563 | 1,548 |
| Short-term notes payable | — | 177 |
| Current portion of notes payable due to related parties | 1,696 | — |
| Short-term notes payable of variable interest entities due to related parties | 303 | — |
| Current portion of royalties payable due to related parties | 613 | 177 |
| Current portion of operating lease liabilities | 71 | 98 |
| Total current liabilities | 5,325 | 2,230 |
| Royalties payable due to related parties | 10,743 | 9,068 |
| Operating lease liabilities | 114 | 13 |
| Notes payable of variable interest entities, net of discount | 1,297 | — |
| Notes payable due to related parties | — | 1,561 |
| Deferred tax liability | 1,545 | 3,141 |
| Total liabilities | 19,024 | 16,013 |
| Commitments and Contingencies (see Note 16) | ||
| Stockholders' Equity | ||
| Preferred Stock, $0.0001 par value, 10,000,000 shares authorized | ||
| Series A Convertible Preferred Stock, $0.0001 par value, 7,203 shares designated; 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024 | — | — |
| Series B Convertible Preferred Stock, $0.0001 par value, 3,000 shares designated; 2,229 and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | — | — |
| Series X Convertible Preferred Stock, $0.0001 par value, 15,404 shares designated; 12,656 shares issued and outstanding as of September 30, 2025 and December 31, 2024 | — | — |
| Common stock, $0.0001 par value, 60,000,000 shares authorized; 1,647,105 and 421,296 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | — | — |
| Additional paid-in capital | 310,539 | 304,109 |
| Accumulated deficit | (303,757) | (292,352) |
| Total stockholders' equity attributable to Catheter Precision, Inc. | 6,782 | 11,757 |
| Non-controlling interest | (333) | — |
| Total stockholders' equity | 6,449 | 11,757 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $25,473 | $27,770 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.